![Jason Cole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Cole
No más puestos en curso
Perfil
Jason F.
Cole is Chief Executive Officer & Director at Zag Bio, Inc. since 2025.
Mr. Cole serves as Director at Massachusetts Biotechnology Council.
Mr. Cole is Secretary & Director at bluebird bio (UK) Ltd. since 2016.
Former roles include Chairman & Chief Executive Officer at SalioGen Therapeutics, Inc. Secretary, Senior Vice President & General Counsel at CombinatoRx, Inc. from 2006 to 2011.
Secretary, Senior Vice President & General Counsel at Neuromed Pharmaceuticals, Inc. Chief Financial, Accounting & Strategy Officer at bluebird bio, Inc. in 2022.
Secretary & Executive VP-Corporate Development at Zalicus, Inc. from 2012 to 2014.
Attorney-Corporate & Securities at Ropes & Gray LLP in 2006.
Education includes undergraduate degree from Dartmouth College and graduate degree from Columbia Law School.
Cargos activos de Jason Cole
| Empresas | Cargo | Inicio |
|---|---|---|
bluebird bio (UK) Ltd.
 bluebird bio (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Director/Miembro de la Junta | 14/03/2016 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Jason Cole.
| Empresas | Cargo | Fin |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Director Financiero/CFO | 14/10/2022 |
Zalicus, Inc.
 Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Consejero General | 05/03/2014 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Consejero General | 06/08/2010 |
Neuromed Pharmaceuticals, Inc.
 Neuromed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops chronic pain drugs | Consejero General | 27/01/2010 |
Ropes & Gray LLP
 Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2006 |
Formación de Jason Cole.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
57
Relaciones de 1er grado
10
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology Develops new medicines built from synergistic combinations of approved drugs | Health Technology |
Neuromed Pharmaceuticals, Inc.
Neuromed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops chronic pain drugs | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
Columbia Law School
 Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ropes & Gray LLP
Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Health Technology |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology Develops non-viral gene therapies | Health Technology |
- Bolsa de valores
- Insiders
- Jason Cole
